Back to search

Netherlands· NL-2d244e6aa2e4

Minims Lidocaine-Fluoresceine, oogdruppels, oplossing

A fluorescein, kombinationen product containing fluoresceïne dinatrium + lidocainehydrochloride 1-water, registered in Netherlands by Bausch + Lomb Ireland Limited. The same ATC class is registered in 7 of our 19 countries.

ATC S01JA51

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMinims Lidocaine-Fluoresceine, oogdru…ATCS01JA51REGISTER NO.NL-2d244e6aa2e4PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Fluorescein, kombinationen is registered in 7 of 19 countries.

Countries holding a registration under ATC S01JA51 (fluorescein, kombinationen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 4 of them publish a price we can compare per daily dose

Fluorescein, kombinationen · ATC S01JA51

7 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUORESCEÏNE DINATRIUM + LIDOCAINEHYDROCHLORIDE 1-WATER
Manufacturer
Bausch + Lomb Ireland Limited
Country
Netherlands (NL)
ATC code
S01JA51
ATC class
Fluorescein, Kombinationen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    10165

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fluorescein, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluorescein, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Cyprus · Lidocaine & Fluorescein Bausch + Lomb
  • Spain · Lidocaína/Fluoresceína Minims
  • Greece · Lidocaine & Fluorescein Bausch + Lomb
  • Hungary · Lidocaine/Fluorescein Health‐med
  • Ireland · Minims
  • Italy · Minims Diagnostico Con Anestetico
  • Malta · Minims
  • Sweden · Lidokain-Fluorescein Bausch & Lomb

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7d17d4e4-7a67-47a7-9ced-646de9c001d4
GET /v1/drugs/7d17d4e4-7a67-47a7-9ced-646de9c001d4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10165_smpc.pdf",
  "strength": null,
  "atc_label": "Fluorescein, Combinations",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg10165",
  "excipients": [
    "POVIDON (E 1201)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "FLUORESCEÏNE DINATRIUM",
    "LIDOCAINEHYDROCHLORIDE 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h10165.pdf",
  "authorised_at": "1984/02/24",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "10165",
  "additional_monitoring": "N"
}

See everything about fluorescein, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.